JP2022551066A5 - - Google Patents

Info

Publication number
JP2022551066A5
JP2022551066A5 JP2022520062A JP2022520062A JP2022551066A5 JP 2022551066 A5 JP2022551066 A5 JP 2022551066A5 JP 2022520062 A JP2022520062 A JP 2022520062A JP 2022520062 A JP2022520062 A JP 2022520062A JP 2022551066 A5 JP2022551066 A5 JP 2022551066A5
Authority
JP
Japan
Prior art keywords
methyl
dihydroxy
biphenyl
pentyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022520062A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022551066A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2020/051330 external-priority patent/WO2021062559A1/en
Publication of JP2022551066A publication Critical patent/JP2022551066A/ja
Publication of JP2022551066A5 publication Critical patent/JP2022551066A5/ja
Pending legal-status Critical Current

Links

JP2022520062A 2019-10-02 2020-10-02 カンナビノイド誘導体 Pending JP2022551066A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962909363P 2019-10-02 2019-10-02
US62/909,363 2019-10-02
US202062966418P 2020-01-27 2020-01-27
US62/966,418 2020-01-27
PCT/CA2020/051330 WO2021062559A1 (en) 2019-10-02 2020-10-02 Cannabinoid derivatives

Publications (2)

Publication Number Publication Date
JP2022551066A JP2022551066A (ja) 2022-12-07
JP2022551066A5 true JP2022551066A5 (cg-RX-API-DMAC10.html) 2023-10-11

Family

ID=75336687

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022520062A Pending JP2022551066A (ja) 2019-10-02 2020-10-02 カンナビノイド誘導体

Country Status (4)

Country Link
US (1) US12325709B2 (cg-RX-API-DMAC10.html)
EP (1) EP4037676A4 (cg-RX-API-DMAC10.html)
JP (1) JP2022551066A (cg-RX-API-DMAC10.html)
WO (1) WO2021062559A1 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3994114A4 (en) 2019-07-04 2023-08-16 Canopy Growth Corporation CANNABINOID DERIVATIVES
WO2021007663A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
EP3997098A4 (en) 2019-07-12 2023-10-11 Canopy Growth Corporation Cannabinoid derivatives
WO2021007661A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
US12084407B2 (en) 2019-11-26 2024-09-10 Canopy Growth Corporation Cannabigerol derivatives and use thereof as cannabinoid receptor modulators
US12617765B2 (en) 2019-12-09 2026-05-05 Canopy Growth Corporation Cannabinoid derivatives
IL312785B2 (en) 2020-05-19 2026-06-01 Cybin Irl Ltd Deuterated tryptamine derivatives and methods of use
WO2022105810A1 (zh) * 2020-11-17 2022-05-27 中国科学院上海药物研究所 一类间苯二酚化合物及其制备方法以及在神经系统疾病中的应用
US20250019345A1 (en) * 2021-11-10 2025-01-16 London Pharmaceuticals And Research Corporation New cannabinoid-gabapentinoid conjugates and uses thereof
WO2024231957A1 (en) * 2023-05-11 2024-11-14 Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) 2'-{heterocyclyl (aryl/alkyl) methyl}-cannabidiol compounds and process for preparation thereof

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69829574T2 (de) * 1997-08-26 2005-09-15 Kumiai Chemical Industry Co., Ltd. Biarylalkylencarbaminsäure-derivate und fungizide für landwirtschaft und gartenbau
US7285687B2 (en) * 2002-04-25 2007-10-23 Virginia Commonwealth University Cannabinoids
MX2007001943A (es) 2004-08-17 2007-05-09 Galderma Res & Dev Nuevos compuestos biaromaticos activadores de los receptores del tipo receptor activado del proliferador de peroxisoma (ppar) y su uso en composiciones cosmeticas o farmaceuticas.
US8633175B2 (en) 2006-08-09 2014-01-21 Glaxosmithkline Llc Compounds as antagonists or inverse agonists at opioid receptors
WO2008096769A1 (ja) 2007-02-08 2008-08-14 Daiichi Sankyo Company, Limited 置換されたセルコスポラミド誘導体を含有する医薬
AU2009243756B2 (en) 2008-05-05 2013-06-27 Sanofi-Aventis Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
JP5766617B2 (ja) 2009-02-20 2015-08-19 ユニバーシティ・オブ・カンザス 修飾された糖部分を有するノボビオシン類似体
US9254272B2 (en) * 2011-11-30 2016-02-09 Sutter West Bay Hospitals Resorcinol derivatives
US9517989B2 (en) * 2012-10-17 2016-12-13 Northeastern University 2-cycloalkyl resorcinol cannabinergic ligands
EP2762134A1 (en) * 2013-02-04 2014-08-06 Bioversys AG Composition for treatment of pathogens that are resistant to tetracyclines
CN105555766A (zh) 2013-07-18 2016-05-04 诺华股份有限公司 作为补体因子d抑制剂的氨基甲基-联芳基衍生物及其应用
ES2547354T3 (es) 2013-09-03 2015-10-05 Symrise Ag Mezclas de compuestos cannabinoides, su preparación y uso
EP3226847A2 (en) * 2014-12-04 2017-10-11 Servicio Andaluz De Salud Use of cannabinoids as ceramide-generating anticancer agents in tumors of the hematopoietic and lymphoid tissues
US9717683B1 (en) 2016-06-29 2017-08-01 Ep Pharma, Llc Low-temperature inhalation administration of cannabinoid entities
US11466283B2 (en) 2016-08-18 2022-10-11 Canopy Growth Corporation Plants and methods for increasing and decreasing synthesis of cannabinoids
US10640482B2 (en) * 2017-07-21 2020-05-05 University Of South Florida Synthesis of cannabinoids
WO2019234728A1 (en) 2018-06-04 2019-12-12 Al&Am Pharmachem Ltd. Cannabinolic acid derivatives and uses thereof
TW202024023A (zh) * 2018-09-03 2020-07-01 瑞士商赫孚孟拉羅股份公司 治療性化合物及其使用方法
CA3138732A1 (en) 2018-11-30 2020-06-04 Canopy Growth Corporation Water-soluble formulations of cannabinoids or cannabis-derived compounds, methods of making and use
WO2020107119A1 (en) 2018-11-30 2020-06-04 Canopy Growth Corporation Compositions comprising a cannabinoid or a cannabis-derived compound, methods of making and use
WO2020198874A1 (en) * 2019-04-04 2020-10-08 Scf Pharma Inc. Cannabidiolic acid monoglycerides, derivatives, and uses thereof
EP3994114A4 (en) 2019-07-04 2023-08-16 Canopy Growth Corporation CANNABINOID DERIVATIVES
US20220242844A1 (en) 2019-07-04 2022-08-04 Canopy Growth Corporation Cannabinoid derivatives
WO2021007663A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
EP3997098A4 (en) 2019-07-12 2023-10-11 Canopy Growth Corporation Cannabinoid derivatives
WO2021007660A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
WO2021007659A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
WO2021007661A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
WO2021062557A1 (en) 2019-10-02 2021-04-08 Canopy Growth Corporation Cannabinoid derivatives
JP2023503330A (ja) 2019-11-26 2023-01-27 キャノピー グロウス コーポレイション カンナビノイド誘導体
US12084407B2 (en) 2019-11-26 2024-09-10 Canopy Growth Corporation Cannabigerol derivatives and use thereof as cannabinoid receptor modulators
US20230122510A1 (en) 2019-11-26 2023-04-20 Canopy Growth Corporation Cannabinoid derivatives
US20230059582A1 (en) 2019-12-09 2023-02-23 Canopy Growth Corporation Cannabinoid derivatives
US12617765B2 (en) 2019-12-09 2026-05-05 Canopy Growth Corporation Cannabinoid derivatives

Similar Documents

Publication Publication Date Title
JP2022551067A5 (cg-RX-API-DMAC10.html)
JP2022540434A5 (cg-RX-API-DMAC10.html)
JP2023503330A5 (cg-RX-API-DMAC10.html)
JP2022539400A5 (cg-RX-API-DMAC10.html)
JP2023503601A5 (cg-RX-API-DMAC10.html)
JP7642707B2 (ja) カルバモイルフェニルアラニノール類縁体およびその使用
ES2313391T3 (es) 1,1a,5,5a-tetrahidro-3-tia-ciclopropa(a)pentalenos: derivados de tiofeno triciclico como agonistas del receptor s1p1/edg1.
JP2022540432A5 (cg-RX-API-DMAC10.html)
SK284068B6 (sk) Ester odvodený od substituovanej fenylcyklohexylovej zlúčeniny, spôsob jeho prípravy a použitie
US7741355B2 (en) Small-molecule modulators of TRP-p8 activity
RU2012120387A (ru) Замещенные производные 4-аминоциклогексана
JP2013507374A (ja) Gタンパク質共役受容体88の修飾因子
RU2008144415A (ru) Композиции, полезные в качестве ингибиторов потенциалзависимых натриевых каналов
RU2012129737A (ru) Замещенные бензамидные производные
JP2022540586A5 (cg-RX-API-DMAC10.html)
RU2015149528A (ru) 2-фенилимидазо[1,2-а]пиримидины в качестве визуализирующих средств
JP2008013556A (ja) 新規ナフタレン化合物、その製造法、およびそれを含有する薬学的組成物
EP2888239B1 (en) Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes
JP2013538198A5 (cg-RX-API-DMAC10.html)
US6566554B1 (en) Aminobenzophenones as inhibitors of IL-1β and TNF-α
JP2021515004A5 (cg-RX-API-DMAC10.html)
CA2716961A1 (fr) Composes derives d'azetidines, leur preparation et leur application en therapeutique
FR2843964A1 (fr) Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
CN101115728B (zh) 三唑取代的氨基二苯甲酮化合物
AU5806900A (en) Aminobenzophenones as inhibitors of il-1beta and tnf-alpha